In situ analysis of protein S-glutathionylation in lung tissue using glutaredoxin-1-catalyzed cysteine derivatization

American Journal of Pathology

Volumn 175, Issue 1, 2009, Pages 36-45

  Aesif, Scott W ^a   Anathy, Vikas ^a   Havermans, Marije ^a   Guala, Amy S ^a   Ckless, Karina ^a,b   Taatjes, Douglas J ^a   Janssen Heininger, Yvonne M W ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYSTEINE; GLUTAREDOXIN; GLUTAREDOXIN 1; GLUTATHIONE; NITROUS OXIDE; OXYGEN; PROTEIN S; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS MUCOSA; CATALYSIS; CONJUGATION; CONTROLLED STUDY; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG INJURY; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN S GLUTATHIONYLATION; RESPIRATORY EPITHELIUM;

EID: 67649962996     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080736     Document Type: Article

References (39)

1. Janssen-Heininger YM, Mossman BT, Heintz NH, Forman HJ, Kalyanaraman B, Finkel T, Stamler JS, Rhee SG, van der Vliet A: Redoxbased regulation of signal transduction: principles, pitfalls, and promises. Free Radic Biol Med 2008, 45:1-17
2. Shackelford RE, Heinloth AN, Heard SC, Paules RS: Cellular and molecular targets of protein S-glutathiolation. Antioxid Redox Signal 2005, 7:940-950
3. Ghezzi P, Bonetto V, Fratelli M: Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation. Antioxid Redox Signal 2005, 7:964-972
4. Shelton MD, Chock PB, Mieyal JJ: Glutaredoxin: role in reversible protein S-glutathionylation and regulation of redox signal transduction and protein translocation. Antioxid Redox Signal 2005, 7:348-366
5. Gallogly MM, Mieyal JJ: Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. Curr Opin Pharmacol 2007, 7:381-391
6. Xiao R, Lundstrom-Ljung J, Holmgren A, Gilbert HF: Catalysis of thiol/disulfide exchange: glutaredoxin 1 and protein-disulfide isomerase use different mechanisms to enhance oxidase and reductase activities, J Biol Chem 2005, 280:21099-21106
7. Clavreul N, Bachschmid MM, Hou X, Shi C, Idrizovic A, Ido Y, Pimentel D, Cohen RA: S-glutathiolation of p21ras by peroxynitrite mediates endothelial insulin resistance caused by oxidized low-density lipoprotein. Arterioscler Thromb Vasc Biol 2006, 26:2454-2461
8. Klatt P, Molina EP, De Lacoba MG, Padilla CA, Martinez-Galesteo E, Barcena JA, Lamas S: Redox regulation of c-Jun DNA binding by reversible S-glutathiolation. FASEB J 1999, 13:1481-1490
9. Reynaert NL, van der Vliet A, Guala AS, McGovern T, Hristova M, Pantano C, Heintz NH, Heim J, Ho YS, Matthews DE, Wouters EF, Janssen-Heininger YM: Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta, Proc Natl Acad Sci USA 2006, 103:13086-13091
10. Fernandes AP, Holmgren A: Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid Redox Signal 2004, 6:63-74
11. Reynaert NL, Ckless K, Guala AS, Wouters EF, van der Vliet A, Janssen-Heininger YM: In situ detection of S-glutathionylated proteins following glutaredoxin-1 catalyzed cysteine derivatization. Biochim Biophys Acta 2006, 1760:380-387
12. Berndt C, Lillig CH, Holmgren A: Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system. Am J Physiol Heart Circ Physiol 2007, 292:H1227-H1236
13. Sagemark J, Elgan TH, Burglin TR, Johansson C, Holmgren A, Berndt KD: Redox properties and evolution of human glutaredoxins. Proteins 2007, 68:879-892
14. Ho YS, Xiong Y, Ho DS, Gao J, Chua BH, Pai H, Mieyal JJ: Targeted disruption of the glutaredoxin 1 gene does not sensitize adult mice to tissue injury induced by ischemia/reperfusion and hyperoxia. Free Radic Biol Med 2007, 43:1299-1312
15. Peltoniemi MJ, Rytila PH, Harju TH, Soini YM, Salmenkivi KM, Ruddock LW, Kinnula VL: Modulation of glutaredoxin in the lung and sputum of cigarette smokers and chronic obstructive pulmonary disease. Respir Res 2006, 7:133
16. Reynaert NL, Wouters EF, Janssen-Heininger YM: Modulation of glutaredoxin-1 expression in a mouse model of allergic airway disease. Am J Respir Cell Mol Biol 2007, 36:147-151
17. Peltoniemi M, Kaarteenaho-Wiik R, Saily M, Sormunen R, Paakko P, Holmgren A, Soini Y, Kinnula VL: Expression of glutaredoxin is highly cell specific in human lung and is decreased by transforming growth factor-beta in vitro and in interstitial lung diseases in vivo. Hum Pathol 2004, 35:1000-1007
18. Akerboom TP, Sies H: Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol 1981, 77:373-382
19. Akerboom TP, Bilzer M, Sies H: The relationship of biliary glutathione disulfide efflux and intracellular glutathione disulfide content in perfused rat liver. J Biol Chem 1982, 257:4248-4252
20. DeLucia AJ, Mustafa MG, Hussain MZ, Cross CE: Ozone interaction with rodent lung: III. Oxidation of reduced glutathione and formation of mixed disulfides between protein and nonprotein sulfhydryls, J Clin Invest 1975, 55:794-802
21. Fratelli M, Demol H, Puype M, Casagrande S, Villa P, Eberini I, Vandekerckhove J, Gianazza E, Ghezzi P: Identification of proteins undergoing glutathionylation in oxidatively stressed hepatocytes and hepatoma cells. Proteomics 2003, 3:1154-1161
22. Cheng G, Ikeda Y, Iuchi Y, Fujii J: Detection of S-glutathionylated proteins by glutathione S-transferase overlay. Arch Biochem Biophys 2005, 435:42-49
23. Piemonte F, Petrini S, Gaeta LM, Tozzi G, Bertini E, Devito R, Boldrini R, Marcellini M, Ciacco E, Nobili V: Protein glutathionylation increases in the liver of patients with non-alcoholic fatty liver disease, J Gastroenterol Hepatol 2008, 23:e457-e464
24. Gan ZR, Wells WW: Purification and properties of thioltransferase. J Biol Chem 1986, 261:996-1001
25. Poynter ME, Persinger RL, Irvin CG, Butnor KJ, van Hirtum H, Blay W, Heintz NH, Robbins J, Hemenway D, Taatjes DJ, Janssen-Heininger Y: Nitrogen dioxide enhances allergic airway inflammation and hyperresponsiveness in the mouse. Am J Physiol Lung Cell Mol Physiol 2006, 290:L144-L152
26. Otterbein LE, Otterbein SL, Ifedigbo E, Liu F, Morse DE, Fearns C, Ulevitch RJ, Knickelbein R, Flavell RA, Choi AM: MKK3 mitogenactivated protein kinase pathway mediates carbon monoxide-induced protection against oxidant-induced lung injury. Am J Pathol 2003, 163:2555-2563
27. Alcorn JF, van der Velden J, Brown AL, McElhinney B, Irvin CG, Janssen-Heininger YM: c-Jun N-terminal kinase 1 is required for the development of pulmonary fibrosis. Am J Respir Cell Mol Biol 2009, 40:422-432
28. Izbicki G, Segel MJ, Christensen TG, Conner MW, Breuer R: Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol 2002, 83:111-119
29. Poynter ME, Irvin CG, Janssen-Heininger YM: A prominent role for airway epithelial NF-kappa B activation in lipopolysaccharide-induced airway inflammation. J Immunol 2003, 170:6257-6265
30. Day BJ: Antioxidants as potential therapeutics for lung fibrosis. Antioxid Redox Signal 2008, 10:355-370
31. Kinnula VL, Fattman CL, Tan RJ, Oury TD: Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. Am J Respir Crit Care Med 2005, 172:417-422
32. Gutscher M, Pauleau AL, Marty L, Brach T, Wabnitz GH, Samstag Y, Meyer AJ, Dick TP: Real-time imaging of the intracellular glutathione redox potential. Nat Methods 2008, 5:553-559
33. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992, 119:493-501
34. Ogino T, Packer L, Maguire JJ: Neutrophil antioxidant capacity during the respiratory burst: loss of glutathione induced by chloramines. Free Radic Biol Med 1997, 23:445-452
35. Carr AC, Winterbourn CC: Oxidation of neutrophil glutathione and protein thiols by myeloperoxidase-derived hypochlorous acid. Biochem J 1997, 327:275-281
36. Crapo JD, Barry BE, Chang LY, Mercer RR: Alterations in lung structure caused by inhalation of oxidants. J Toxicol Environ Health 1984, 13:301-321
37. Crapo JD, Marsh-Salin J, Ingram P, Pratt PC: Tolerance and crosstolerance using NO2 and O2 II. Pulmonary morphology and morphometry. J Appl Physiol 1978, 44:370-379
38. Kuwano K, Nakashima N, Inoshima I, Hagimoto N, Fujita M, Yoshimi M, Maeyama T, Hamada N, Watanabe K, Hara N: Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias. Eur Respir J 2003, 21:232-240
39. Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, Nicholson AG, Verbeken EK, Verschakelen J, Flower CD, Capron F, Petruzzelli S, De Vuyst P, van den Bosch JM, Rodriguez-Becerra E, Corvasce G, Lankhorst I, Sardina M, Montanari M: High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005, 353:2229-2242